Atish Patel
0000-0002-5549-9166
Publication & Citation Trends
Publications
0 total
Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport
Cited by 17
Semantic Scholar
The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors OA
Cited by 36
Semantic Scholar
Mechanistic and Pharmacological Insights into Modulation of ABC Drug Transporters by Tyrosine Kinase Inhibitors
Cited by 3
Semantic Scholar
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo OA
Cited by 25
Semantic Scholar
Abstract 4419: Design, synthesis and biological evaluation of N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide analog as a promising inhibitor of the multidrug resistance-linked ABCG2 transporter
Cited by 0
Semantic Scholar
Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway. OA
Cited by 36
Semantic Scholar
ABC Transporter Modulatory Drugs from Marine Sources: A New Approach to Overcome Drug Resistance in Cancer
Cited by 1
Semantic Scholar
Research Topics
Drug Transport and Resistance Mechanisms
(36)
Cancer therapeutics and mechanisms
(15)
Cholangiocarcinoma and Gallbladder Cancer Studies
(9)
HIV/AIDS drug development and treatment
(7)
Chronic Myeloid Leukemia Treatments
(6)
Affiliations
National Institutes of Health
St. John's University
Wayne State University
The Barbara Ann Karmanos Cancer Institute
National Institute of Allergy and Infectious Diseases